Ignite Creation Date:
2024-05-06 @ 7:15 PM
Last Modification Date:
2024-10-26 @ 3:03 PM
Study NCT ID:
NCT05948033
Status:
RECRUITING
Last Update Posted:
2023-07-17
First Post:
2023-07-09
Brief Title:
CD70 Targeted CAR-T Cells in CD70 Positive RelapsedRefractory Lymphoma
Sponsor:
Chinese PLA General Hospital
Organization:
Chinese PLA General Hospital
Organization Data
Organization:
Chinese PLA General Hospital
Class:
OTHER
Study ID:
CHN-PLAGH-BT-081
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chinese PLA General Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Han weidong
Responsible Party Title:
Director of Biotherapeutic Department
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Chinese PLA General Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| UTC Therapeutics Inc | INDUSTRY |